{
  "ptid_time": "070_S_4793_2012-09-27",
  "img_path": "/data/qiuhui/data/adni/images/070_S_4793/2012-09-27/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 91,208 mm³, 94.0% above the reference mean. With a Z-score of 2.73 (99.7th percentile), this represents significant enlargement; hippocampal volume measures 6,457 mm³, 7.3% below the reference mean. With a Z-score of -0.63 (26.3th percentile), this represents normal volume ; whole brain volume measures 940,128 mm³, 8.7% below the reference mean. With a Z-score of -1.13 (12.8th percentile), this represents mild atrophy. ",
  "text_data": "Age is 85.3 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Gastrointestinal; Renal-Genitourinary; Smoking. MMSE: 24.0. MoCA: 18.0. Logical Memory: 4.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.45 SUVR (significant elevated); Amyloid beta: 443.90 pg/mL (moderate reduced); Total tau: 293.90 pg/mL (normal ); Phosphorylated tau: 30.19 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (consistent with atrophy), mild whole-brain atrophy, and normal hippocampal volume. Cognitive scores (MMSE 24, MoCA 18) suggest mild cognitive impairment, while biomarker findings (elevated AV45, moderately reduced Aβ, and mildly elevated P-tau) support Alzheimer's pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **High**  \n\n(Note: The absence of APOE4 does not rule out AD, and the biomarker profile strongly suggests AD pathophysiology despite normal hippocampal volume at this stage.)",
  "timestamp": "2025-07-26T09:04:14.611011"
}